Xiangyu Liu

Title: Innovations of Xiangyu Liu in Immunology

Introduction

Xiangyu Liu is an accomplished inventor based in Cranbury, NJ (US). He has made significant contributions to the field of immunology through his innovative research and development of fusion proteins. His work focuses on enhancing immune responses, which has important implications for vaccine development.

Latest Patents

Xiangyu Liu holds a patent for "Fusion proteins and methods of use." This patent describes compositions that include a fusion protein comprising flagellin and at least one antigen that has an isoelectric point greater than about 7.0. The fusion protein is designed to activate Toll-like Receptor 5, which plays a crucial role in the immune response. The methods outlined in the patent involve administering a composition that includes an antigen fused to a loop of domain 3 of flagellin, aimed at stimulating a protective immune response.

Career Highlights

Xiangyu Liu is currently associated with Vaxinnate Corporation, where he continues to advance his research in immunology. His work has garnered attention for its potential to improve vaccine efficacy and provide better protection against various diseases. With a patent portfolio that includes 1 patent, Liu is recognized for his innovative approach to solving complex immunological challenges.

Collaborations

Xiangyu Liu collaborates with talented individuals in his field, including Langzhou Song and Ge Liu. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in immunology.

Conclusion

Xiangyu Liu's contributions to the field of immunology through his innovative patents and collaborations highlight his commitment to advancing healthcare solutions. His work at Vaxinnate Corporation exemplifies the impact of scientific research on public health.